296 related articles for article (PubMed ID: 20889945)
1. Five unit bolus oxytocin at cesarean delivery in women at risk of atony: a randomized, double-blind, controlled trial.
King KJ; Douglas MJ; Unger W; Wong A; King RA
Anesth Analg; 2010 Dec; 111(6):1460-6. PubMed ID: 20889945
[TBL] [Abstract][Full Text] [Related]
2. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
Borruto F; Treisser A; Comparetto C
Arch Gynecol Obstet; 2009 Nov; 280(5):707-12. PubMed ID: 19229549
[TBL] [Abstract][Full Text] [Related]
3. Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery.
George RB; McKeen D; Chaplin AC; McLeod L
Can J Anaesth; 2010 Jun; 57(6):578-82. PubMed ID: 20238255
[TBL] [Abstract][Full Text] [Related]
4. Intramuscular oxytocin versus intravenous oxytocin to prevent postpartum haemorrhage at vaginal delivery (LabOR trial): study protocol for a randomised controlled trial.
Adnan N; Boland F; Murphy DJ
Trials; 2017 Nov; 18(1):541. PubMed ID: 29141679
[TBL] [Abstract][Full Text] [Related]
5. Ergometrine given during caesarean section and incidence of delayed postpartum haemorrhage due to uterine atony.
Lourens R; Paterson-Brown S
J Obstet Gynaecol; 2007 Nov; 27(8):795-7. PubMed ID: 18097896
[TBL] [Abstract][Full Text] [Related]
6. The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: an up-down sequential allocation dose-response study.
Lavoie A; McCarthy RJ; Wong CA
Anesth Analg; 2015 Jul; 121(1):159-164. PubMed ID: 25902327
[TBL] [Abstract][Full Text] [Related]
7. Oxytocin for labour and caesarean delivery: implications for the anaesthesiologist.
Dyer RA; Butwick AJ; Carvalho B
Curr Opin Anaesthesiol; 2011 Jun; 24(3):255-61. PubMed ID: 21415725
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin requirements at elective cesarean delivery: a dose-finding study.
Carvalho JC; Balki M; Kingdom J; Windrim R
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):1005-10. PubMed ID: 15516392
[TBL] [Abstract][Full Text] [Related]
9. Use of additional oxytocin to reduce blood loss at elective caesarean section: A randomised control trial.
Güngördük K; Asicioglu O; Celikkol O; Olgac Y; Ark C
Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):36-9. PubMed ID: 20218995
[TBL] [Abstract][Full Text] [Related]
10. Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
Balki M; Ronayne M; Davies S; Fallah S; Kingdom J; Windrim R; Carvalho JC
Obstet Gynecol; 2006 Jan; 107(1):45-50. PubMed ID: 16394038
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
Boucher M; Horbay GL; Griffin P; Deschamps Y; Desjardins C; Schulz M; Wassenaar W
J Perinatol; 1998; 18(3):202-7. PubMed ID: 9659650
[TBL] [Abstract][Full Text] [Related]
12. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin.
Rath W
Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):15-20. PubMed ID: 19616358
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
Moertl MG; Friedrich S; Kraschl J; Wadsack C; Lang U; Schlembach D
BJOG; 2011 Oct; 118(11):1349-56. PubMed ID: 21668768
[TBL] [Abstract][Full Text] [Related]
14. Oxytocin at elective caesarean delivery: a dose-finding study in women with obesity.
Peska E; Balki M; Maxwell C; Ye XY; Downey K; Carvalho JCA
Anaesthesia; 2021 Jul; 76(7):918-923. PubMed ID: 33227150
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blind placebo-controlled trial of buccal misoprostol to reduce the need for additional uterotonic drugs during cesarean delivery.
Hernández-Castro F; López-Serna N; Treviño-Salinas EM; Soria-López JA; Sordia-Hernández LH; Cárdenas-Estrada E
Int J Gynaecol Obstet; 2016 Feb; 132(2):184-7. PubMed ID: 26534874
[TBL] [Abstract][Full Text] [Related]
16. Carbetocin at elective Cesarean delivery: a randomized controlled trial to determine the effective dose, part 2.
Anandakrishnan S; Balki M; Farine D; Seaward G; Carvalho JC
Can J Anaesth; 2013 Nov; 60(11):1054-60. PubMed ID: 24158878
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of carbetocin given as an intravenous bolus compared with short infusion for Caesarean section - double-blind, double-dummy, randomized controlled non-inferiority trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Br J Anaesth; 2017 May; 118(5):772-780. PubMed ID: 28498927
[TBL] [Abstract][Full Text] [Related]
18. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial.
Attilakos G; Psaroudakis D; Ash J; Buchanan R; Winter C; Donald F; Hunt LP; Draycott T
BJOG; 2010 Jul; 117(8):929-36. PubMed ID: 20482535
[TBL] [Abstract][Full Text] [Related]
19. Effect of a High-Rate Versus a Low-Rate Oxytocin Infusion for Maintaining Uterine Contractility During Elective Cesarean Delivery: A Prospective Randomized Clinical Trial.
Duffield A; McKenzie C; Carvalho B; Ramachandran B; Yin V; El-Sayed YY; Riley ET; Butwick AJ
Anesth Analg; 2017 Mar; 124(3):857-862. PubMed ID: 28212181
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of carbetocin applied as an intravenous bolus compared to as a short-infusion for caesarean section: study protocol for a randomised controlled trial.
Dell-Kuster S; Hoesli I; Lapaire O; Seeberger E; Steiner LA; Bucher HC; Girard T
Trials; 2016 Mar; 17():155. PubMed ID: 27004531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
